The New Standard for Hospital-Grade Disinfectants
Germizene is a new generation product that kills infectious germs like Staph and Klebsiella for up to 7 days and Kills spores like C.diff 99.9995%
This water-resistant barrier creates a safe environment, offering extended protection for hospitals and communities against infectious diseases.
Staph
C. Diff
Coronaviruses
Applying Germizene
The liquid solution can be applied to any hard, non-porous surface.
After being applied, Germizene’s residual protection layer does not produce any odor and is unnoticeable.
Once dried, Germizene’s liquid mixture forms a protective layer that continues to protect against infectious organisms, including those introduced to the protected area after application.
Germizene Claims the Following
Kills 99.99% of bacteria for 48 hours
Sanitizes for up to 48 hours
Kills 99.99% of odor-causing bacteria for up to 48 hours
Patent documents, SDS sheets and test results available upon request.
Our Leadership
Anthony McCullough
Anthony developed the science behind the product Germizene. Since the 1960’s he has been creating chemistries that are used in the manufacturing of our nation’s products.
Michael McCullough
Michael has worked in the chemical industry for over 28 years. He is the Vice President and leader of national sales at Miller Chemical Technology and Management and is currently serving as the President of Sanikleen, LLC, the parent company of Germizene.
Charlie Martin
Charlie attended Lexington Community College where he pursued a Degree in Nursing.
Charlie shares several patents and trademarks where he played a pivotal role in research and development.
He has done extensive research in the field of infectious diseases working with The University of Kentucky Hospital, Immunology and Infectious Disease departments, Haggard Davis Equine Hospital on development of equine infectious disease control, and extensive experience working closely with several credited efficacy and toxicity testing laboratories preparing testing protocols and other test related documentation.
Ken Bryan
Ken is an independent consultant who works with our company to assist in bringing Germizene to market. He deals with investors, businesses, political staffers, specialist in other fields and consulting firms working to bring together the right group to make our products a success.